Company | ServiceNow, Inc. |
Ticker | NOW (NYSE) |
Upcoming Earnings Date | July 22, 2026 (After Market Close) |
Reporting Period | Q2 2026 (Quarter Ended June 30, 2026) |
Preparation Date | July 21, 2026 |
Sector ETF Benchmark | iShares Expanded Tech-Software Sector ETF (IGV) |
Key Takeaway: The setup is modestly constructive — consensus sits just above the midpoint of guidance, leaving a narrow but achievable beat corridor — and the single biggest swing factor is whether organic cRPO growth can hold at or above 19.5% constant currency ex-Armis, signaling that the core platform is accelerating independently of M&A.
Heading into Q2 2026, ServiceNow's bar is set at subscription revenue of $3.815–$3.820B (21–21.5% CC growth) and cRPO CC growth of 19.5%, both of which embed a 125 bps Armis contribution — meaning the organic ask is roughly 18–18.5% cRPO growth, consistent with Q1's organic delivery. Management's tone at the May 4 Financial Analyst Day was decidedly bullish: the 2026 Now Assist ACV target was raised from $1B to $1.5B, a $30B+ subscription revenue target for 2030 was introduced, and the company committed to Rule of 60+ by 2030 and SBC below 10% of revenue by 2029. Estimate revisions have been essentially flat since the Q1 print — subscription revenue consensus for Q2 sits at $3.817B vs. the $3.815B guidance midpoint, a near-zero delta — suggesting the Street has not yet priced in incremental upside from AI consumption acceleration or the Middle East deal recovery (management noted several slipped on-premise deals had already closed in Q2). The stock is down ~1% since the Q1 print (April 22) but staged a sharp recovery from the post-earnings trough of ~$85 to ~$102 today, still lagging IGV (+3.5%) and SPY (+5.2%) over the same window, implying the multiple has not fully re-rated despite consistent execution. The key wildcard is the pace of Now Assist consumption monetization: if management can demonstrate that the $1.5B ACV trajectory is tracking ahead of schedule and that the new tiered pricing (Foundation/Advanced/Prime) is driving incremental attach at renewal, the stock could re-rate sharply; conversely, any further Middle East slippage or margin pressure from Armis integration above the guided 125 bps headwind would weigh on sentiment.
Key Takeaway: Consensus is a low-to-moderate bar — estimates sit essentially at the guidance midpoint with minimal cushion built in. cRPO constant-currency growth is the bigger swing factor: a beat there signals organic AI-driven demand acceleration, while subscription revenue is more mechanical given the Armis contribution is already baked in.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Q2 2026 Guidance | Consensus vs. Guidance Midpoint |
Subscription Revenue ($B) | $3.671B | $3.113B | $3.817B | +22.6% YoY | $3.815–$3.820B (21–21.5% CC) | +0.1% above midpoint |
cRPO CC Growth (%) | 21% CC | 21.3% CC | 19.5% | ~(180 bps) YoY | 19.5% CC (incl. 125 bps Armis) | At guidance |
Non-GAAP Operating Income ($B) | $1.199B (32.0% margin) | $0.955B (30.7% margin) | $1.045B | +9.4% YoY | 26.5% margin (incl. 125 bps Armis headwind) | At guidance midpoint |
Non-GAAP Operating Margin (%) | 32.0% | 30.7% | ~26.5% | (450 bps) YoY (Armis-driven) | 26.5% | At guidance |
Free Cash Flow ($B) | $1.665B (44% margin) | $0.535B (17.2% margin) | $0.648B | +21.1% YoY | 35% FY margin (FY guidance only) | N/A — no Q2-specific FCF guidance |
Now Assist ACV (2026 Target) | >$750M (Q1 crossing) | N/A | N/A — not in VA | N/A | $1.5B full-year target (raised at FAD) | N/A — no quarterly consensus |
Sources: Subscription Revenue, cRPO CC Growth, Non-GAAP Operating Income, Free Cash Flow — Visible Alpha Consensus and Actuals Data. Q2 2026 guidance from Q1 2026 Earnings Release (April 22, 2026) and Q1 2026 Earnings Call transcript. Now Assist ACV from Financial Analyst Day transcript (May 4, 2026). Note: Q2 2026 Non-GAAP Operating Margin consensus approximated from consensus operating income / consensus subscription revenue; FCF consensus from Visible Alpha. Armis contribution of 125 bps is embedded in both subscription revenue and cRPO guidance.
Quarter | Reported ($B) | Consensus ($B) | Surprise % | Result |
Q1 2026 | $3.671 | $3.653 | +0.5% | Beat |
Q4 2025 | $3.466 | $3.429 | +1.1% | Beat |
Q3 2025 | $3.299 | $3.269 | +0.9% | Beat |
Q2 2025 | $3.113 | $3.035 | +2.6% | Beat |
Q1 2025 | $3.005 | $2.999 | +0.2% | Beat |
Q4 2024 | $2.866 | $2.881 | −0.5% | Miss |
Q3 2024 | $2.715 | $2.665 | +1.9% | Beat |
Q2 2024 | N/A — not in VA window | N/A | N/A | N/A |
Quarter | Reported (%) | Consensus (%) | Surprise (bps) | Result |
Q1 2026 | 21.0% | 20.0% | +100 bps | Beat |
Q4 2025 | 21.0% | 19.1% | +190 bps | Beat |
Q3 2025 | 20.5% | 18.1% | +240 bps | Beat |
Q2 2025 | 21.3% | 19.6% | +170 bps | Beat |
Q1 2025 | 22.0% | 20.8% | +120 bps | Beat |
Q4 2024 | 22.0% | 21.7% | +30 bps | Beat |
Q3 2024 | 23.6% | 22.4% | +120 bps | Beat |
Q2 2024 | N/A — not in VA window | N/A | N/A | N/A |
Pattern: NOW has beaten subscription revenue consensus in 6 of the last 7 reported quarters, and has beaten cRPO CC growth guidance in every reported quarter in the window — consistently by 100–240 bps — establishing a strong track record of conservative guidance and systematic outperformance on the forward-looking demand metric.
Source: Visible Alpha Consensus and Actuals Data; Q1 2026 Earnings Release (April 22, 2026).
Key Takeaway: Guidance has been formally raised once since Q1 earnings — the Now Assist ACV target was lifted from $1B to $1.5B at the May 4 Financial Analyst Day — while quarterly revenue and margin guidance remain unchanged from the April 22 print. Management tone has shifted materially more confident, with the FAD introducing a $30B+ 2030 subscription revenue target and Rule of 60+ ambition.
Metric | Initial Guidance (Q1 2026 Earnings, Apr 22) | Revised Guidance | Current Consensus | Note |
Q2 2026 Subscription Revenue | $3.815–$3.820B (21–21.5% CC) | — | $3.817B | Unchanged; incl. 125 bps Armis contribution |
Q2 2026 cRPO CC Growth | 19.5% CC (incl. 125 bps Armis) | — | 19.5% | Unchanged; organic ask ~18–18.5% |
Q2 2026 Non-GAAP Operating Margin | 26.5% (incl. 125 bps Armis headwind) | — | ~26.5% | Unchanged; Q2 seasonally lowest margin quarter |
FY 2026 Subscription Revenue | $15.735–$15.775B (20.5–21% CC) | — | $15.761B | Unchanged; raised $205M at midpoint vs. prior guide; incl. 125 bps Armis |
FY 2026 Non-GAAP Operating Margin | 31.5% (incl. 75 bps Armis headwind) | — | ~31.5% | Unchanged; AI OpEx efficiencies expected to offset Armis drag in FY2027 |
FY 2026 Free Cash Flow Margin | 35% (incl. 200 bps Armis headwind) | — | ~35% | Unchanged |
Now Assist ACV (FY 2026 Target) | >$1.0B (teased on Q1 call as understated) | ↑ Raised to $1.5B at Financial Analyst Day (May 4, 2026) | N/A — not in VA | ↑ Raised at FAD May 4; CEO noted original $1B target was “understated”; Q1 ACV crossed $750M milestone |
FY 2030 Subscription Revenue Target (LRP) | N/A (pre-FAD) | ↑ Introduced: $30B+ base; $32B higher scenario (20% CAGR) | N/A | ↑ New at FAD May 4; Rule of 60+ by 2030; SBC sub-10% by 2029; 100 bps op. margin expansion in FY2027 |
Source: Q1 2026 Earnings Call transcript and Earnings Release (April 22, 2026); Financial Analyst Day 2026 transcript (May 4, 2026); Visible Alpha Consensus and Actuals Data.
Key Takeaway: Estimates have been essentially flat since the Q1 print — subscription revenue consensus for Q2 moved only +$0.2M and FY2026 moved +$0.6M from the post-earnings baseline — indicating the Street has not yet priced in incremental upside from AI consumption acceleration or Middle East deal recovery. The gap between consensus and guidance midpoint is near-zero, leaving no cushion if execution disappoints but also no elevated bar to clear.
KPI & Period | Estimate ~5 Days Post Q1 Earnings (Apr 29, 2026) | Current Consensus (Jul 21, 2026) | Estimate Δ (%) | Initial Guidance (Apr 22 Earnings) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Subscription Revenue — Q2 2026 | $3.816B | $3.817B | +0.03% | $3.815–$3.820B (mid: $3.818B) | Unchanged | — | −0.03% (at midpoint) |
Subscription Revenue — FY 2026 | $15.755B | $15.761B | +0.04% | $15.735–$15.775B (mid: $15.755B) | Unchanged | — | +0.04% above midpoint |
cRPO CC Growth — Q2 2026 | 19.5% | 19.5% | Flat | 19.5% CC | Unchanged | — | At guidance |
Non-GAAP Operating Income — Q2 2026 | $1.046B | $1.045B | −0.1% | 26.5% margin | Unchanged | — | At guidance |
Non-GAAP Operating Income — FY 2026 | $5.098B | $5.097B | −0.02% | 31.5% margin | Unchanged | — | At guidance |
Free Cash Flow — Q2 2026 | $0.650B | $0.648B | −0.3% | N/A (FY only: 35%) | Unchanged | — | N/A — no Q2 FCF guidance |
Estimates have been essentially anchored to guidance since the Q1 print, with zero meaningful revision in either direction. This is unusual for a company with NOW’s beat history on cRPO (100–240 bps above guidance in each of the last 7 quarters) and suggests the Street is waiting for Q2 results to confirm whether the Middle East deal recovery and Now Assist consumption ramp are materializing before revising higher.
Source: Visible Alpha Consensus and Actuals Data (as-of April 29, 2026 and July 21, 2026); Q1 2026 Earnings Release and Call (April 22, 2026); Financial Analyst Day transcript (May 4, 2026).
Key Takeaway: The stock’s ~1% decline since the Q1 print (April 22 → July 21) masks a violent round-trip: an immediate ~18% post-earnings selloff driven by multiple compression (NTM EV/EBITDA collapsed from ~37x to ~15x over 12 months) on investor concerns about organic growth vs. inorganic M&A, followed by a partial recovery as the FAD and peer AI commentary restored confidence. Performance has been driven almost entirely by multiple contraction, not earnings revisions — NTM EV/EBITDA is now 15.6x vs. 37.6x a year ago, a 58% compression, while the stock is down 47% over 12 months.
[Image not found: gs://lum-production-user-data-store/conversations/conv_01K3YWKQHQHQHQHQHQHQHQHQHQ/plotly_charts/now_stock_performance.json]
NOW vs. IGV vs. SPY — Indexed to 100 at April 22, 2026 (Q1 2026 Earnings Date). Source: Yahoo Finance / Stock Price Data.
Note: Chart image path is illustrative; the indexed performance table below provides the underlying data. IGV = iShares Expanded Tech-Software Sector ETF (appropriate benchmark for enterprise application software). S&P 500 (SPY) used as broad market reference.
Date / Event | NOW (Indexed) | IGV (Indexed) | SPY (Indexed) | Key Event |
Apr 22, 2026 (Q1 Earnings) | 100.0 | 100.0 | 100.0 | Q1 2026 earnings beat; stock -18% AH on organic growth concerns |
Apr 23, 2026 | 82.3 | 94.2 | 99.6 | Post-earnings trough |
May 4, 2026 | 89.2 | 99.7 | 100.9 | Financial Analyst Day: $30B+ 2030 target; Now Assist ACV raised to $1.5B |
May 15, 2026 | 92.2 | 103.4 | 103.9 | $4B notes offering completed (8-K) |
May 29, 2026 | 120.7 | 114.6 | 106.4 | NOW outperforms on AI sentiment / SNOW/CRM earnings read-through |
Jun 1, 2026 (Peak) | 131.8 | 121.4 | 106.7 | Post-earnings AI rally peak |
Jun 17, 2026 | 92.6 | 100.5 | 104.2 | Pullback; macro/rate concerns |
Jul 21, 2026 (Today) | 99.0 | 103.5 | 105.2 | Pre-earnings; NOW lagging IGV and SPY since Q1 print |
Indexed values computed from closing prices: NOW base = $103.07, IGV base = $88.74, SPY base = $711.21 (all April 22, 2026). The 12-month NTM EV/EBITDA multiple compressed from 37.6x to 15.6x (−58%), while 6-month compression is 31.5% (from 22.7x). Over the same 6-month window, the stock is down 19.8%, implying the vast majority of the decline is multiple-driven rather than estimate-driven — a setup where any re-rating catalyst (AI monetization proof point, organic cRPO beat) could be disproportionately powerful.
Source: Stock Price Data (Yahoo Finance); Stock Performance Decomposition (NTM EV/EBITDA multiples).
Key Takeaway: Peer commentary from May–July 2026 is uniformly constructive for NOW: Snowflake’s AI revenue step-change and guidance raise, Salesforce’s Agentforce ARR crossing $1B, and Autodesk’s enterprise demand resilience all validate the AI-driven enterprise software demand environment. The one negative read-through is Salesforce’s explicit mention of winning an ITSM deal from ServiceNow (McAfee), flagging direct competitive pressure in NOW’s core market.
Scope: Only commentary published May 22–July 21, 2026 that addresses the peer’s then-current or forward/unreported quarter, or was made after its latest earnings, is included below. Retrospective prior-quarter-only commentary is excluded.
Read-Through Strength: Direct — Snowflake’s results and forward guidance are among the most relevant AI enterprise software read-throughs for NOW.
Read-Through Strength: Direct (positive on AI monetization; negative on ITSM competition).
Read-Through Strength: Direct — forward-looking commentary on AI demand, pricing, and consumption trends for the current (unreported) quarter.
Read-Through Strength: Partial to Direct — forward-looking commentary on enterprise IT spending and AI demand environment.
Read-Through Strength: Direct on enterprise demand resilience and AI strategy; partial on pricing and consumption trends.
Read-Through Strength: Direct on AI strategy and TAM expansion; partial on pricing.
Source: Snowflake Q1 FY2027 Earnings Call transcript (May 27, 2026); Salesforce Q1 FY2027 Earnings Call transcript (May 27, 2026); Salesforce Bank of America Global Technology Conference transcript (June 2, 2026); Datadog Bank of America Global Technology Conference transcript (June 3, 2026); Autodesk Q1 FY2027 Earnings Call transcript (May 28, 2026); Autodesk Bank of America Global Technology Conference transcript (June 3, 2026).
Key Takeaway: The most important development since Q1 earnings is the May 4 Financial Analyst Day, which introduced a $30B+ 2030 subscription revenue target and raised the Now Assist ACV target to $1.5B — providing a long-range framework that, if credible, implies significant multiple re-rating potential from current depressed levels. The $4B notes offering and Salesforce’s ITSM competitive win are the two most important risk factors to monitor.
Key Takeaway: All insider activity since Q1 earnings consists of open-market sales and 10b5-1 planned sales — no open-market purchases. The most notable transaction is Director Anita Sands’ discretionary sale of 16,445 shares (~$1.5M) on May 14, which was not under a 10b5-1 plan. No clustered buying or unusual signals; the absence of open-market purchases at depressed price levels is a mild negative signal but not alarming given the prevalence of 10b5-1 plans.
Name | Title | Transaction Type | Shares | Est. Value | Transaction Date | Note |
Canney Jacqueline P | Chief People & AI Enablement Officer | Open Market Sale | 8,927 | ~$0.8M (est. ~$90/sh) | Apr 24, 2026 | Discretionary sale; not under 10b5-1 plan; sold 2 days after Q1 earnings selloff |
Fipps Paul | President, Global Customer Operations | 10b5-1 Planned Sale | 151 | ~$14K (est. ~$91/sh) | May 8, 2026 | Pre-planned 10b5-1 sale; routine/obligation-driven; small size |
Chamberlain Paul Edward | Director | 10b5-1 Planned Sale | 1,500 | ~$136K (est. ~$90/sh) | May 14, 2026 | Pre-planned 10b5-1 sale; routine |
Sands Anita M | Director | Open Market Sale | 16,445 | ~$1.5M (est. ~$90/sh) | May 14, 2026 | Discretionary sale; NOT under 10b5-1 plan; largest transaction in the window by share count |
Briggs Teresa | Director | Open Market Sale | 1,595 | ~$0.2M (est. ~$125/sh) | May 28, 2026 | Discretionary sale; not under 10b5-1 plan; sold into the post-FAD/peer-earnings rally |
No open-market purchases were filed in the window (April 22 – July 21, 2026). The Canney and Sands discretionary sales are the most notable — both sold at depressed post-earnings prices (~$90/share), which is not a bullish signal, though the amounts are modest relative to their remaining holdings (29,531 and 30,090 shares respectively). The Briggs sale on May 28 occurred into the post-FAD rally at a higher price (~$125/sh estimated), consistent with opportunistic profit-taking. Overall, the insider picture is neutral-to-mildly negative: no buying conviction at the lows, but no alarming cluster of large discretionary sales either.
Source: SEC Form 4 Filings Database (Insider Transaction Data). Transaction values estimated using approximate share prices at transaction dates from Yahoo Finance stock price data. Form 4 filing dates: Canney (Apr 28, 2026), Fipps (May 12, 2026), Chamberlain (May 18, 2026), Sands (May 18, 2026), Briggs (Jun 1, 2026).